Furthermore, the suppressor protein p53 is mutated in HT-29 cells (Goldberg et al, 1996; Gobert et al, 1999) and recent data showed that p53 mutations may promote cancer progression by augmenting NF-κB activation in the context of chronic inflammation (Weisz et al, 2007). The gene discussed is TP53; the disease is cancer.